CVE:HTL - Hamilton Thorne Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$1.09 -0.01 (-0.91 %)
(As of 11/20/2018 06:24 AM ET)
Previous CloseC$1.10
Today's RangeC$1.07 - C$1.10
52-Week RangeC$0.68 - C$1.28
Volume42,154 shs
Average Volume128,746 shs
Market CapitalizationN/A
P/E Ratio23.70
Dividend YieldN/A
Hamilton Thorne Ltd., together with its subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets. The company offers clinical lasers, such as LYKOS and ZILOS-tk lasers, as well as clinical laser software and hardware for clinical assisted reproduction; and research lasers, including XYRCOS and XYClone lasers for stem cell research, gene targeting, knock out mouse production, SCNT, ICSI, IVF, and assisted hatching applications, as well as Stiletto lasers for isolation of cells of interest, ablation of unwanted cells, and precision scoring of cell colonies. It also provides clinical sperm analysis (CASA) products comprising IVOS II Clinical and CEROS II Clinical, as well as Human Motility II and Dimensions II Strict Morphology software to clinics, hospitals, and laboratories; animal and research CASA systems, and motility software packages; and various sperm analyzer options. In addition, the company offers sperm analysis accessories, such as Accu-beads+ for use in counting procedures in semen analysis; 2X-CEL disposable semen analysis slides; IDENT Stains for determining sperm motility and concentration; VIADENT stain to determine viable sperm count, concentration, and percentage from a motile sample; and MiniTherm Stage Warmer for CASA and manual sperm motility analysis. Further, it offers IMSI-Strict, an automated software solution for live sperm morphology under high magnification; Oosight imaging system for research purposes; and CIVA, a custom software to capture images/video and annotate. The company sells its products to pharmaceutical and biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Hamilton Thorne Ltd. is based in Beverly, Massachusetts.

Receive HTL News and Ratings via Email

Sign-up to receive the latest news and ratings for HTL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange CVE
Industry Medical Devices
Current SymbolCVE:HTL
Previous Symbol


Debt-to-Equity Ratio44.84
Current Ratio1.82
Quick Ratio1.26


Trailing P/E Ratio23.70
Forward P/E Ratio36.33
P/E GrowthN/A

Sales & Book Value

Annual SalesC$27.54 million
Price / Sales4.72
Cash FlowC$0.06 per share
Price / Cash19.47
Book ValueC$0.21 per share
Price / Book5.24


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares119,228,000
Market CapC$0.00
OptionableNot Optionable

Hamilton Thorne (CVE:HTL) Frequently Asked Questions

What is Hamilton Thorne's stock symbol?

Hamilton Thorne trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HTL."

When is Hamilton Thorne's next earnings date?

Hamilton Thorne is scheduled to release their next quarterly earnings announcement on Tuesday, November 20th 2018. View Earnings Estimates for Hamilton Thorne.

What is the consensus analysts' recommendation for Hamilton Thorne?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hamilton Thorne in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Hamilton Thorne.

Has Hamilton Thorne been receiving favorable news coverage?

Media coverage about HTL stock has trended somewhat positive recently, InfoTrie reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Hamilton Thorne earned a media sentiment score of 1.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 9.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next few days.

Who are some of Hamilton Thorne's key competitors?

Who are Hamilton Thorne's key executives?

Hamilton Thorne's management team includes the folowing people:
  • Ms. Meg Spencer, Co-Founder & Chairman
  • Mr. David B. Wolf, Pres, CEO & Director
  • Mr. Diarmaid H. Douglas-Hamilton, Co-Founder, Sr. VP of R&D, CTO, Corp. Sec. and Director
  • Mr. Michael W. Bruns, VP of Fin. & CFO (Age 61)
  • Mr. Keith F. Edwards, Sr. VP & GM

How do I buy shares of Hamilton Thorne?

Shares of HTL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Hamilton Thorne's stock price today?

One share of HTL stock can currently be purchased for approximately C$1.09.

What is Hamilton Thorne's official website?

The official website for Hamilton Thorne is

How can I contact Hamilton Thorne?

Hamilton Thorne's mailing address is 100 Cummings Ctr Ste 465e, BEVERLY, MA 01915-6143, United States. The company can be reached via phone at +1-978-9212050.

MarketBeat Community Rating for Hamilton Thorne (CVE HTL)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  88
MarketBeat's community ratings are surveys of what our community members think about Hamilton Thorne and other stocks. Vote "Outperform" if you believe HTL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HTL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel